Cambridge Investment Research Advisors, Inc. Pro Phase Labs, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $36.4 Billion
- Q3 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 14,795 shares of PRPH stock, worth $4,438. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,795Holding current value
$4,438% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding PRPH
# of Institutions
30Shares Held
2.98MCall Options Held
13.7KPut Options Held
0-
Sykon Capital LLC Harrison, NY645KShares$193,4380.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA532KShares$159,5750.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA398KShares$119,3740.0% of portfolio
-
Geode Capital Management, LLC Boston, MA303KShares$90,8780.0% of portfolio
-
Accretive Wealth Partners, LLC Parsippany, NJ250KShares$75,0000.04% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $4.81M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...